NUR 540 Module 5 Short Paper Example

Narrow Airways, Normal Carbon Dioxide: The Pathophysiology of an Asthma Exacerbation in a 9-Year-Old

[Student Name]

Southern New Hampshire University

NUR 540: Advanced Pathophysiology Across the Life Span

Short Paper

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

Narrow Airways, Normal Carbon Dioxide: The Pathophysiology of an Asthma Exacerbation in a 9-Year-Old

In asthma, long-standing airway inflammation, twitchy airways and narrowing that comes and goes all feed one another, and exacerbations are the moments when that interaction tips toward respiratory failure (Global Initiative for Asthma [GINA], 2024). In school-age children, most attacks follow a viral respiratory infection. This paper explains the pathophysiology of a composite 9-year-old's exacerbation, from the chronic inflammation beneath it to the gas exchange failure it produced. It argues that the child's signs, from the prolonged expiration to a carbon dioxide level that looked normal but was not, can each be traced to airway narrowing and trapped air, and that each rescue drug was chosen to reverse a specific part of that process.

The Case

A 9-year-old with persistent asthma, prescribed a low-dose inhaled corticosteroid that the family admitted was used only occasionally, developed a runny nose and cough two days before admission. On the evening of arrival the child could speak only a word or two between breaths, sat leaning forward and used neck and intercostal muscles to breathe. Breathing ran at 38 per minute and the pulse at 136; oxygen saturation measured 89% on room air. Wheezing was heard throughout both lungs on expiration, which was markedly prolonged. Peak flow was 45% of the child's personal best. A venous blood gas showed pH 7.36 and carbon dioxide 44 mm Hg. After nebulized albuterol with ipratropium, oral prednisolone and oxygen, the child's work of breathing eased over the next hour, and the child was admitted for continued treatment.

The Inflamed Airway Beneath the Attack

Most childhood asthma is driven by type 2 inflammation. Allergens and airway irritants activate epithelial cells and type 2 helper T cells, which release interleukin-4, interleukin-5 and interleukin-13. These cytokines promote IgE production, recruit and sustain eosinophils, increase mucus-producing goblet cells and make smooth muscle more reactive (Rogers, 2023). Over time the airway wall thickens, with a thickened basement membrane and more smooth muscle, a process called remodeling. The result is an airway that is already narrowed and quick to constrict further, which is why a trigger that would give another child a cold gives this child an emergency.

The inhaled corticosteroid this child was prescribed is meant to suppress exactly this inflammation. Irregular use left the airways inflamed and hyperresponsive when the virus arrived.

How the Virus Set Off the Attack

Respiratory viruses such as rhinovirus infect the airway epithelium, damage it and trigger release of signals that amplify type 2 inflammation already present. The response unfolds in two phases. In the early phase, within minutes of the trigger, mast cells release histamine, leukotrienes and prostaglandins that contract airway smooth muscle. In the late phase, hours later, eosinophils, neutrophils and lymphocytes arrive, and the airway wall becomes swollen and fills with mucus. By the time this child arrived, two days into the cold, the narrowing reflected all three processes at once: smooth muscle spasm, wall edema and mucus plugs. Only the first responds quickly to bronchodilators, which explains why steroids are started early even when a bronchodilator brings relief.

Air Trapping, Work of Breathing and Oxygen

Narrowed airways obstruct airflow most during expiration, when airways naturally narrow as the lungs empty. Air enters but cannot fully leave before the next breath, so the lungs hyperinflate. Hyperinflation flattens the diaphragm and puts the respiratory muscles at a mechanical disadvantage, which is why the child recruited neck and chest wall muscles and sat forward. The prolonged expiration and widespread expiratory wheeze are the sounds of air forced through narrowed tubes.

Obstruction is uneven. Some regions of the lung are poorly ventilated but still well perfused, so blood leaves them without full oxygenation. This mismatch between ventilation and perfusion, rather than hypoventilation, is the main cause of the child's oxygen saturation of 89% (Rogers, 2023). The fast heart rate reflects both hypoxemia and the effort of breathing, and albuterol itself can raise it further.

Why a Normal Carbon Dioxide Level Is a Warning

Early in an exacerbation, children breathe fast and blow off carbon dioxide, so the level in the blood is usually low. A child breathing 38 times a minute should have a low carbon dioxide level. A value of 44 mm Hg, within the normal range, means the child is no longer able to clear carbon dioxide despite maximal effort: obstruction and fatigue have reduced effective alveolar ventilation. In a child with this degree of distress, a normal carbon dioxide level signals approaching respiratory failure, and a rising one demands escalation. This is the single most important interpretation in the case, because the number looks reassuring to anyone who reads it without the respiratory rate beside it.

How the Rescue Drugs Work

Albuterol, a short-acting beta-2 agonist, stimulates receptors on airway smooth muscle, raising cyclic AMP and relaxing the muscle within minutes. Ipratropium blocks muscarinic receptors, removing cholinergic tone that contributes to bronchoconstriction; adding it to albuterol is recommended for moderate to severe exacerbations in the emergency setting. Systemic corticosteroids reduce the late-phase inflammation and edema that bronchodilators cannot reach, although their effect takes hours to appear. Oxygen treats the hypoxemia caused by mismatched ventilation and perfusion (GINA, 2024). After discharge, the key step is the controller: national guidance supports daily inhaled corticosteroids for persistent asthma in children, and, for many children with moderate disease, one inhaler combining a steroid with formoterol that serves for both daily control and relief (Cloutier et al., 2020).

Age and This Patient

Children's airways are narrow, and resistance rises steeply as the radius falls, roughly with the fourth power of the radius, so a small amount of swelling or mucus causes a large increase in resistance. Children also have more compliant chest walls and less efficient collateral ventilation between lung units, and they can compensate with fast breathing until they tire suddenly. Viral infections are the dominant triggers at this age. Adherence depends on parents and on the school, where rescue inhalers must be available. For this child, the attack is also a sign of undertreated chronic disease, which makes the discharge plan, an asthma action plan, a controller the family can use consistently and follow-up, as important as the treatment in the emergency department.

Conclusion

This child's attack began long before the cold, in airways kept inflamed by type 2 signaling and left untreated by an unused controller. The virus added bronchospasm, swelling and mucus, trapping air, straining the respiratory muscles and mismatching ventilation with blood flow. A normal carbon dioxide level in a child breathing this fast signaled that compensation was failing. Albuterol, ipratropium, steroids and oxygen each reversed one part of that process, and a better controller plan is the treatment that should prevent the next one.

References

Cloutier, M. M., Baptist, A. P., Blake, K. V., Brooks, E. G., Bryant-Stephens, T., DiMango, E., Dixon, A. E., Elward, K. S., Hartert, T., Krishnan, J. A., Lemanske, R. F., Ouellette, D. R., Pace, W. D., Schatz, M., Skolnik, N. S., Stout, J. W., Teach, S. J., Umscheid, C. A., & Walsh, C. G. (2020). 2020 focused updates to the asthma management guidelines: A report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Journal of Allergy and Clinical Immunology, 146(6), 1217-1270. https://doi.org/10.1016/j.jaci.2020.10.003

Global Initiative for Asthma. (2024). Global strategy for asthma management and prevention. https://ginasthma.org/reports/

Rogers, J. L. (Ed.). (2023). McCance & Huether's pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.